During the past decade, Saadat Ansari Internal Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 7 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saadat Ansari Internal Medicine" #1 sponsor was "Pfizer" with 4 trials, followed by "Kowa Research Institute, Inc." with 2 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored, "Horizon Pharma Rheumatology LLC" with 1 trials sponsored and "Tioga Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saadat Ansari Internal Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "RTI Health Solutions" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Saadat Ansari Internal Medicine" are "Cardiovascular Disease" (2 trials), "Severe Hypertriglyceridemia" (2 trials), "Diabetic Nephropathies" (1 trials), "Diarrhea Predominant Irritable Bowel Syndrome" (1 trials) and "Hyperkalemia" (1 trials). Many other conditions were trialed in "Saadat Ansari Internal Medicine" in a lesser frequency.

Most popular intervention types in "Saadat Ansari Internal Medicine" are "Drug" (8 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Fenofibrate" (2 trials), "K-877" (2 trials), "Placebo (for K-877)" (2 trials) and "Asimadoline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saadat Ansari Internal Medicine" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Saadat Ansari Internal Medicine". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Saadat Ansari Internal Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Saadat Ansari Internal Medicine, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".